Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2025
Pharma News, 2025
Researchers expect FDA to approve a twice-yearly shot that reduces risk of HIV infection by 96%
A twice-yearly injection reduces the risk of HIV infection by 96%. That’s according to a clinical trial led by physicians at Emory University and the Grady Health System.
China’s NMPA prioritises HUTCHMED’s lung cancer therapy review
China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application (NDA) for HUTCHMED’s ORPATHYS (savolitinib) and ...
Testing Services Market Outlook, 2025-2035
Testing Services Market Outlook, 2025-2035 - Dominated by Charles River Laboratories Int'l, Eurofins Scientific, SGS, WuXi AppTec, and Pace Analytical Services
IIT Guwahati and Bose Institute develop injectable hydrogel for cancer
The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel designed to release anti-cancer therapies to tumou...
50
51
52
53
54
